FDA Turns Kratom's Future In US Dietary Supplement Market Into History

FDA Commissioner Scott Gottlieb says kratom's apparently increasing use "as an alternative or adjunct to opioid use" has made enforcement on the ingredient more of a priority for FDA, and "given the scope of this crisis, we must do more."

More from Ingredients & Safety

More from HBW Insight